These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11258167)

  • 1. Recap of FDA product approvals--2000.
    Traynor K
    Am J Health Syst Pharm; 2001 Mar; 58(5):363, 366-8. PubMed ID: 11258167
    [No Abstract]   [Full Text] [Related]  

  • 2. Recap of FDA product approvals--1999.
    Miller JL
    Am J Health Syst Pharm; 2000 Mar; 57(5):418, 421-2. PubMed ID: 10711519
    [No Abstract]   [Full Text] [Related]  

  • 3. Recap of FDA product approvals--2001.
    Traynor K
    Am J Health Syst Pharm; 2002 Feb; 59(4):321-2, 324. PubMed ID: 11885393
    [No Abstract]   [Full Text] [Related]  

  • 4. Recap of FDA product approvals--2002.
    Am J Health Syst Pharm; 2003 Feb; 60(4):310, 312. PubMed ID: 12625212
    [No Abstract]   [Full Text] [Related]  

  • 5. Innovating by developing new uses of already-approved drugs: trends in the marketing approval of supplemental indications.
    DiMasi JA
    Clin Ther; 2013 Jun; 35(6):808-18. PubMed ID: 23726388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDA drug approvals from 1994 to 1995.
    Wynn RL
    Gen Dent; 1996; 44(2):114, 116, 118. PubMed ID: 8690259
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA drug approvals in 1993-94.
    Wynn RL
    Gen Dent; 1995; 43(1):12, 14. PubMed ID: 7758913
    [No Abstract]   [Full Text] [Related]  

  • 8. Characteristics of rare disease marketing applications associated with FDA product approvals 2006-2010.
    Pariser AR; Slack DJ; Bauer LJ; Warner CA; Tracy LA
    Drug Discov Today; 2012 Aug; 17(15-16):898-904. PubMed ID: 22564486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDA proposes higher fees for drug approvals to cover postmarketing surveillance.
    Tanne JH
    BMJ; 2007 Jan; 334(7586):177. PubMed ID: 17255596
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA new drug approvals in 2006.
    Wynn RL
    Gen Dent; 2007; 55(4):275-9. PubMed ID: 17682633
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA new drug approvals in 2004.
    Wynn RL
    Gen Dent; 2005; 53(4):246-8. PubMed ID: 16158789
    [No Abstract]   [Full Text] [Related]  

  • 12. Significant FDA approvals in 1994.
    Rheinstein PH
    Am Fam Physician; 1995 Mar; 51(4):888-90. PubMed ID: 7887364
    [No Abstract]   [Full Text] [Related]  

  • 13. Significant FDA approvals in 2000.
    McGinnis TJ
    Am Fam Physician; 2001 May; 63(10):2061-4. PubMed ID: 11388719
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA new drug approvals in 2007.
    Wynn RL
    Gen Dent; 2008; 56(6):506-10. PubMed ID: 18810906
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA new drug approvals in 2005.
    Wynn RL
    Gen Dent; 2006; 54(4):230-3. PubMed ID: 16903192
    [No Abstract]   [Full Text] [Related]  

  • 16. Significant FDA approvals in 1996.
    Rheinstein PH
    Am Fam Physician; 1997 Jun; 55(8):2855-8. PubMed ID: 9191461
    [No Abstract]   [Full Text] [Related]  

  • 17. 2015 FDA drug approvals.
    Mullard A
    Nat Rev Drug Discov; 2016 Feb; 15(2):73-6. PubMed ID: 26837582
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA new drug approvals in 2009.
    Wynn RL
    Gen Dent; 2010; 58(4):280-4. PubMed ID: 20591770
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA approvals for the first 6 months of 2016.
    Mullard A
    Nat Rev Drug Discov; 2016 Jul; 15(8):523. PubMed ID: 27469224
    [No Abstract]   [Full Text] [Related]  

  • 20. 2012 FDA drug approvals.
    Mullard A
    Nat Rev Drug Discov; 2013 Feb; 12(2):87-90. PubMed ID: 23370234
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.